From Sommelier to Leading a High-Growth Pharma Company
Listen now
Description
S4 Bonus Ep2 - Gilly Regev is co-founder and Chief Strategy & Innovation Officer of SaNOtize, an exciting young pharmaceutical company based in Vancouver, Canada. The company has developed a disruptive, first-in-class technology that delivers the antimicrobial benefits of Nitric Oxide to treat a variety of infectious conditions.   In this episode, Gilly revisits her early experiences as a sommelier, shares the inside story of SaNOtize from inception to today, and describes the key challenges in the pharma sector. She also opens up about being in the army and her personal leadership philosophies and tactics. Key topics include:   ●      Strategies for building and motivating a core team ●      How to choose meaningful company values ●      Importance of ‘doing the hard things’   This episode is sponsored by Deel - No more headaches with trying to manage your global workforce, compliantly hire and pay employees with Deel.com. Visit Deel.com by clicking here https://bit.ly/4f0yBYH Gilly Regev - https://www.linkedin.com/in/gilly-regev/ Follow this show on your podcast app and join us on The Startup Sensations Podcast LinkedIn page. Watch video highlights on YouTube. We love hearing your feedback, so email us at [email protected].  Learn more about your ad choices. Visit podcastchoices.com/adchoices
More Episodes
Published 11/12/24
S4 Bonus Ep1 - Raj Singh, Managing Partner at JLL Spark in Silicon Valley, shares his insights with Bulent & Shelley about what investors are looking for in you as a founder of a UK or US startup company.   In this episode, Raj shares his insights into the different approaches taken by VCs on...
Published 11/05/24
S4 Ep12 - Faisal Khan, an influential figure at the Institute of Directors, serves as the chair for the southern region and is a pivotal member of the IoD's expert advisory group for Science, Innovation, and Technology. In this engaging episode, Faisal Khan sits down with Shelley and Bulent to...
Published 08/21/24